| Name | Title | Contact Details |
|---|
RAAS BLOOD PRODUCTS CO., LTD. is a Agoura Hills, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Mavericks highly innovative platform, COBRA™, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.
Porex Corporation is a Fairburn, GA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
At Prospero, we believe a person`s care should be determined by preference, not dictated by their medical condition. That`s why we are building a new kind of healthcare company, providing loving care and support for a growing population of people and their families facing serious illness. The rising challenge for people and their families, the healthcare system, and our country is significant, and that`s why we must meet it head on by hiring the best people with a heart for service. At Prospero, we empower people to live their best lives now with loving and compassionate home-based care and support.
Global Health Strategies (GHS) is an international consulting company that specializes in global health communications, advocacy, research and strategy. We focus on public health issues that impact developing nations and emerging markets. Our clients include leading foundations, industry, NGOs, government agencies, academic institutions and product development. Our work is driven by a passion for improving the health and wellbeing of individuals and communities around the world. We offer the skills, knowledge and goal-driven efficiency to enhance our clients` efforts to address some of the world’s toughest health challenges, including HIV/AIDS, tuberculosis, malaria, polio eradication, sexual and reproductive health and vaccines. GHS has offices in New York, New Delhi, Rio de Janeiro and Beijing, and supports work in countries in Africa, Asia, Europe and the Americas.